Skip to main content

Test Price

2,300 AED

✅ Home Collection Available

Cultured AFB Antitubercular DST Rapid 12-Drug Panel in Dubai | 2300 AED | DHA Licensed

Executive Summary & Core Metrics

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.

Logistics: Secure Medical Courier Solid Tissue Specimen Retrieval – sample collection is conducted strictly on isolated M. tuberculosis complex cultures; mobile home phlebotomy is disabled for safety.

Clinical Guidance: Complimentary telephonic post-test guidance for result interpretation by DHA-licensed practitioners.

Insurance Support: Direct billing verification via WhatsApp +971 54 548 8731.

Turnaround Time: 21 days from receipt of culture isolate.

Drug Coverage: 12 drugs including bedaquiline, linezolid, clofazimine, and all first-line agents.

Methodology: Automated fluorescent MIC (Sensititre / BACTEC MGIT 960).

Test Overview & Methodology

The Cultured AFB Antitubercular DST Rapid 12-Drug Panel is a high-complexity, automated fluorescent susceptibility test that precisely identifies resistance to 12 pivotal anti-tuberculosis drugs from a pure Mycobacterium tuberculosis complex isolate, enabling tailored, resistance-guided therapy within the UAE’s DHA framework.

Our Test: Cultured AFB DST Rapid 12-Drug Panel Closest Alternative: Conventional DST
Methodology: Automated Fluorescent MIC (Sensititre / BACTEC MGIT 960) with real-time growth detection Methodology: Manual proportion method on solid Löwenstein-Jensen medium
Turnaround: Report within 21 days Turnaround: 28-42 days (often delayed by contamination)
Drug Coverage: 12 drugs including bedaquiline, linezolid, clofazimine, fluoroquinolones, and all first-line agents Drug Coverage: Typically only 4-5 first-line drugs; second-line testing requires separate, slower procedures
Sensitivity: 99.9% with full MIC quantification (ISO 9001 certified) Sensitivity: ~92-95% with categorical (resistant/susceptible) breakpoints only

Physician Insight & Safety Protocols

“As a general practitioner with a focus on infectious diseases, I see firsthand how critical it is to obtain a comprehensive resistance profile for tuberculosis patients. This 12-drug panel gives us the confidence to prescribe the most effective regimen without delay. Our DHA-licensed team is here to support you at every step.”

— Dr. Ajay Singh, General Practitioner, DHA Registration ID: 36234132

Medication Advisory

Do not discontinue any prescribed anti-tuberculosis medication without consulting your doctor. Interrupting therapy based solely on DST results can lead to relapse or drug resistance. Always follow your physician’s clinical correlation.

Safety Exclusion Criteria & Emergency Red Flags

  • Exclusions: This test is not suitable if the patient has received empiric multi-drug TB therapy for less than 2 weeks (culture may be negative); if the submitted isolate is mixed/contaminated; or if the specimen is not a pure growth of M. tuberculosis complex.
  • Emergency Red Flags: If during sample handling or at any time you experience massive hemoptysis, severe shortness of breath, or high persistent fever ≥39°C, seek immediate emergency medical care. Our medical courier team is trained to recognize and escalate these situations.

Patient FAQ & Clinical Guidance

1. What is the turnaround time for results?

Your final report is ready in 21 days from sample receipt, with interim MIC results often available earlier.

2. Does this cover drug resistance to new TB drugs like bedaquiline and linezolid?

Yes, the 12-drug panel includes first- and second-line agents such as bedaquiline, linezolid, clofazimine, and fluoroquinolones.

3. How should I prepare for the sample collection?

No special preparation is required; a pure culture isolate is obtained from your existing specimen or our medical courier retrieves it from the laboratory.

UAE Regulatory & Data Privacy Adherence

Compliance with UAE Healthcare Laws

This service strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical testing and patient consent comply with Federal Decree-Law No. 4 of 2016 on Medical Liability. Our laboratory holds ISO 9001:2015 certification and operates under DHA facility license No. 1143.

Clinical & Logistical Metadata

Test Name Cultured AFB Antitubercular DST Rapid 12-Drug Panel
Price (AED) 2,300
Turnaround Time 21 days from receipt of culture isolate
Sample Type / Matrix Isolated Mycobacterium tuberculosis complex culture (Archival Tissue Specimen) – Secure Medical Courier Solid Tissue Specimen Retrieval
Methodology Used Automated Fluorescent MIC (Sensititre / BACTEC MGIT 960)
ICD-10-CM Code A15.0
LOINC Code 52829-4
DHA Facility License & Lab Address DHA Facility License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians